- Home
- APPF vs CORT Comparison
APPF vs CORT Comparison
Compare APPF & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APPF
- CORT
- Stock Information
- Founded
- APPF 2006
- CORT 1998
- Country
- APPF United States
- CORT United States
- Employees
- APPF N/A
- CORT N/A
- Industry
- APPF Computer Software: Prepackaged Software
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- APPF Technology
- CORT Health Care
- Exchange
- APPF Nasdaq
- CORT Nasdaq
- Market Cap
- APPF 9.5B
- CORT 7.6B
- IPO Year
- APPF 2015
- CORT N/A
- Fundamental
- Price
- APPF $280.22
- CORT $69.53
- Analyst Decision
- APPF Buy
- CORT Strong Buy
- Analyst Count
- APPF 6
- CORT 4
- Target Price
- APPF $309.83
- CORT $139.00
- AVG Volume (30 Days)
- APPF 241.3K
- CORT 644.6K
- Earning Date
- APPF 10-23-2025
- CORT 10-29-2025
- Dividend Yield
- APPF N/A
- CORT N/A
- EPS Growth
- APPF 64.56
- CORT N/A
- EPS
- APPF 5.55
- CORT 1.11
- Revenue
- APPF $862,674,000.00
- CORT $716,080,000.00
- Revenue This Year
- APPF $21.09
- CORT $30.62
- Revenue Next Year
- APPF $17.60
- CORT $37.68
- P/E Ratio
- APPF $50.26
- CORT $62.97
- Revenue Growth
- APPF 19.47
- CORT 25.71
- 52 Week Low
- APPF $189.01
- CORT $37.82
- 52 Week High
- APPF $326.04
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- APPF 54.23
- CORT 45.26
- Support Level
- APPF $275.65
- CORT $67.32
- Resistance Level
- APPF $284.48
- CORT $74.79
- Average True Range (ATR)
- APPF 5.80
- CORT 2.36
- MACD
- APPF -0.47
- CORT 0.14
- Stochastic Oscillator
- APPF 52.99
- CORT 29.58
About APPF AppFolio Inc.
AppFolio Inc provides cloud-based software solutions for the real estate industry. Its property management software offers property managers an end-to-end solution to their business needs. The group's products include cloud-based property management software (Appfolio Property Manager). Its solutions are AppFolio Property Manager Core, AppFolio Property Manager Plus, and AppFolio Property Manager Max. It also offers value-added services, such as screening, risk mitigation, and electronic payment services. Its markets are Single-Family, Multifamily, Student Housing, Affordable Housing, Community Associations, Commercial, and Investment Management. The business activity of the firm predominantly functions in the United States and it generates revenue in the form of subscription fees.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.